Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ANIDULAFUNGIN vs REZAFUNGIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ANIDULAFUNGIN vs REZAFUNGIN: Safety Overview

Metric ANIDULAFUNGIN REZAFUNGIN
Total FAERS Reports 701 108
Deaths Reported 325 12
Death Rate 46.4% 11.1%
Hospitalizations 287 20
Average Patient Age 53.3 yrs 53.8 yrs
% Female Patients 40.0% 54.3%
FDA Approval Date Feb 17, 2006 Mar 22, 2023
Manufacturer Roerig Melinta Therapeutics, LLC
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Prescription